QIV-HD clinical development and phase 3 safety and immunogenicity study results

Chang, Lee-Jah

i

QIV-HD clinical development and phase 3 safety and immunogenicity study results

Public Domain

October 23. 2019
By Chang, Lee-Jah
Series: ACIP: Influenza

File Language:

English

Details

Personal Author:

Chang, Lee-Jah
Corporate Authors:

Sanofi Pasteur.
Subjects:

Influenza Vaccines
Series:

ACIP: Influenza
Document Type:

Still Image
Name as Subject:

ACIP meeting: 2019 Oct ; ACIP meeting: 2019 Oct
Genre:

Presentation ; Conference Publications
Volume:

201903
Issue:

010403
Collection(s):

Advisory Committee on Immunization Practices (ACIP)
Main Document Checksum:

urn:sha-512:305f5321d8054cb0a6ad96bf5d52cbd00e4b262ebed6a08356d1c05ead8d319cee88ba4b4697c1f83d982ec79df59ac8e8a2b7c398514eb93aa9c92077e00786
Download URL:

https://stacks.cdc.gov/view/cdc/83327/cdc_83327_DS1.pdf
File Type:

[PDF - 1.24 MB ]

File Language:

English

ON THIS PAGE

Details Related Documents

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.